NCT02488746

Brief Summary

Prospective observational trial. A full thickness resection of gastric subepithelial tumors is performed after application of full thickness sutures underneath the tumor with the GERDX(TM) device. Hypothesis: This endoscopic method is feasible, effective and safe.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
5

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Mar 2015

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2015

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

June 26, 2015

Completed
6 days until next milestone

First Posted

Study publicly available on registry

July 2, 2015

Completed
3.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2018

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2018

Completed
Last Updated

December 9, 2016

Status Verified

December 1, 2016

Enrollment Period

3.5 years

First QC Date

June 26, 2015

Last Update Submit

December 8, 2016

Conditions

Outcome Measures

Primary Outcomes (1)

  • Rate of cases in which a complete macroscopic en bloc resection of the gastric subepithelial tumor could be achieved

    intraoperative

Secondary Outcomes (5)

  • Rate of cases in which a complete microscopic resection of the gastric subepithelial tumor could be achieved

    within one week after resection (as soon as result of pathologic analysis of resected specimen is available)

  • Rate of complications (bleeding, perforation)

    6 months after resection

  • Duration of hospitalization

    within one week after resection

  • Number of participants with local or systemic recidive of tumor

    6 months after resection

  • Number of participants with needs of surgical therapy or endoscopic re-resection

    6 months after resection

Study Arms (1)

EFTR-GERDX

Endoscopic full thickness resection of subepithelial gastric tumors using the GERDX suturing device.

Device: GERDX(TM)

Interventions

GERDX(TM)DEVICE

Endoscopic full thickness resection of subepithelial gastric tumors using the GERDX suturing device.

EFTR-GERDX

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients in which a subepithelial gastric tumor has been detected (in our hospital, other hospitals or by transferring doctor).

You may qualify if:

  • presence of a subepithelial gastric tumor with signs of potential malignancy in endoscopic ultrasound
  • age 18 years or older
  • participant has given informed consent

You may not qualify if:

  • tumor size \> 40 mm (endosonographic measurement) or large extramural tumor mass
  • signs of systemic dissemination of tumor
  • current presence of a different neoplastic disease (except after successful curative treatment without continued medication)
  • former surgery or disease of esophagus or stomach that impedes insertion of the suturing device
  • moribund patient
  • limited possibility to give informed consent (e.g. language barrier, psychiatric disease)
  • pregnancy and lactation period

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Klinikum Ludwigsburg

Ludwigsburg, Baden-Wurttemberg, 71640, Germany

Location

MeSH Terms

Conditions

Stomach NeoplasmsGastrointestinal Stromal Tumors

Condition Hierarchy (Ancestors)

Gastrointestinal NeoplasmsDigestive System NeoplasmsNeoplasms by SiteNeoplasmsDigestive System DiseasesGastrointestinal DiseasesStomach DiseasesNeoplasms, Connective TissueNeoplasms, Connective and Soft TissueNeoplasms by Histologic Type

Study Officials

  • Karel Caca, Prof. Dr.

    Klinikum Ludwigsburg

    STUDY CHAIR

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 26, 2015

First Posted

July 2, 2015

Study Start

March 1, 2015

Primary Completion

September 1, 2018

Study Completion

September 1, 2018

Last Updated

December 9, 2016

Record last verified: 2016-12

Locations